These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23681165)

  • 1. Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD.
    Bari A; Robbins TW
    Psychopharmacology (Berl); 2013 Nov; 230(1):89-111. PubMed ID: 23681165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal and monoaminergic contributions to stop-signal task performance in rats.
    Bari A; Mar AC; Theobald DE; Elands SA; Oganya KC; Eagle DM; Robbins TW
    J Neurosci; 2011 Jun; 31(25):9254-63. PubMed ID: 21697375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
    Arnsten AF; Pliszka SR
    Pharmacol Biochem Behav; 2011 Aug; 99(2):211-6. PubMed ID: 21295057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.
    Newman LA; Darling J; McGaughy J
    Psychopharmacology (Berl); 2008 Sep; 200(1):39-50. PubMed ID: 18568443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay among catecholamine systems: dopamine binds to alpha2-adrenergic receptors in birds and mammals.
    Cornil CA; Ball GF
    J Comp Neurol; 2008 Dec; 511(5):610-27. PubMed ID: 18924139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and therapeutic directions in ADHD: Specificity in the PFC.
    Levy F
    Behav Brain Funct; 2008 Feb; 4():12. PubMed ID: 18304369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using noradrenaline receptor antagonists in female C57BL/6JRj mice.
    Klem L; Nielsen MM; Gestsdóttir SB; Frandsen SL; Prichardt S; Andreasen JT
    Psychopharmacology (Berl); 2023 Aug; 240(8):1629-1650. PubMed ID: 37329343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches.
    Sarter M; Paolone G
    Behav Neurosci; 2011 Dec; 125(6):825-35. PubMed ID: 22122146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing effects of preterm birth on the dopaminergic and noradrenergic pathways in the frontal cortex and hippocampus of guinea pigs.
    Moloney RA; Palliser HK; Dyson RM; Pavy CL; Berry M; Hirst JJ; Shaw JC
    Dev Neurobiol; 2024 Apr; 84(2):93-110. PubMed ID: 38526217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocretin-1 receptor antagonism improves inhibitory control during the Go/No-Go task in highly motivated, impulsive male mice.
    Metha J; Ji Y; Braun C; Nicholson JR; De Lecea L; Murawski C; Hoyer D; Jacobson LH
    Psychopharmacology (Berl); 2024 Jun; ():. PubMed ID: 38886189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.
    Eagle DM; Baunez C
    Neurosci Biobehav Rev; 2010 Jan; 34(1):50-72. PubMed ID: 19615404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines: Knowledge and understanding in the 1960s, now, and in the future.
    Stanford SC; Heal DJ
    Brain Neurosci Adv; 2019; 3():2398212818810682. PubMed ID: 32166174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phasic activation of individual neurons in the locus ceruleus/subceruleus complex of monkeys reflects rewarded decisions to go but not stop.
    Kalwani RM; Joshi S; Gold JI
    J Neurosci; 2014 Oct; 34(41):13656-69. PubMed ID: 25297093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and impulsivity: behavioral and neural basis of response control.
    Bari A; Robbins TW
    Prog Neurobiol; 2013 Sep; 108():44-79. PubMed ID: 23856628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of noradrenergic attenuation by clonidine on inhibition in the stop signal task.
    Logemann HN; Böcker KB; Deschamps PK; Kemner C; Kenemans JL
    Pharmacol Biochem Behav; 2013 Sep; 110():104-11. PubMed ID: 23792541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task.
    Carli M; Invernizzi RW
    Front Neural Circuits; 2014; 8():58. PubMed ID: 24966814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting impulsivity in Parkinson's disease using atomoxetine.
    Kehagia AA; Housden CR; Regenthal R; Barker RA; Müller U; Rowe J; Sahakian BJ; Robbins TW
    Brain; 2014 Jul; 137(Pt 7):1986-97. PubMed ID: 24893708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain Comorbidities with Attention Deficit: A Narrative Review of Clinical and Preclinical Research.
    Liang HB; He WY; Liu YP; Wang HB
    J Pain Res; 2024; 17():1055-1065. PubMed ID: 38505503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Reward to Anhedonia-Dopamine Function in the Global Mental Health Context.
    Dresp-Langley B
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles.
    Matt RA; Westhorpe FG; Romuar RF; Rana P; Gever JR; Ford AP
    Front Mol Biosci; 2023; 10():1214102. PubMed ID: 37664183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.